These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3632727)

  • 1. Effect of succinylacetone administration on brain heme metabolism and behavior in mice.
    Kang K; Anderson-Burham LA; Bloomer JR
    Biochem Pharmacol; 1987 Sep; 36(18):3084-6. PubMed ID: 3632727
    [No Abstract]   [Full Text] [Related]  

  • 2. Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells.
    Ebert PS; Hess RA; Frykholm BC; Tschudy DP
    Biochem Biophys Res Commun; 1979 Jun; 88(4):1382-90. PubMed ID: 289386
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of succinylacetone (4,6-dioxoheptanoic acid) on delta-aminolevulinate synthase activity and the content of heme in monolayers of chick embryo liver cells.
    Schoenfeld N; Greenblat Y; Epstein O; Atsmon A
    Biochim Biophys Acta; 1982 Dec; 721(4):408-17. PubMed ID: 7159602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S; Kappas A
    J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid.
    Tschudy DP; Hess RA; Frykholm BC
    J Biol Chem; 1981 Oct; 256(19):9915-23. PubMed ID: 7275988
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of succinylacetone on heme and cytochrome P450 synthesis in hepatocyte culture.
    Giger U; Meyer UA
    FEBS Lett; 1983 Mar; 153(2):335-8. PubMed ID: 6617864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of porphobilinogen deaminase, uroporphyrinogen decarboxylase, and alpha- and beta-globin mRNAs during differentiation of mouse erythroleukemic cells. Effects of succinylacetone.
    Grandchamp B; Beaumont C; de Verneuil H; Nordmann Y
    J Biol Chem; 1985 Aug; 260(17):9630-5. PubMed ID: 3860503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of succinylacetone on dimethylsulfoxide-mediated induction of heme pathway enzymes in mouse friend virus-transformed erythroleukemia cells.
    Beaumont C; Deybach JC; Grandchamp B; da Silva V; de Verneuil H; Nordmann Y
    Exp Cell Res; 1984 Oct; 154(2):474-84. PubMed ID: 6592100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron utilization in rabbit reticulocytes. A study using succinylacetone as an inhibitor or heme synthesis.
    Ponka P; Wilczynska A; Schulman HM
    Biochim Biophys Acta; 1982 Feb; 720(1):96-105. PubMed ID: 7059619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibitory activity of succinylacetone: studies with Walker 256 carcinosarcoma, Novikoff hepatoma and L1210 leukemia.
    Tschudy DP; Ebert PS; Hess RA; Frykholm BC; Atsmon A
    Oncology; 1983; 40(2):148-54. PubMed ID: 6828292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of hematoporphyrin uptake and in vitro-growth inhibition of L1210 leukemia cells by succinylacetone.
    Ebert PS; Hess RA; Tschudy DP
    J Natl Cancer Inst; 1985 Mar; 74(3):603-8. PubMed ID: 3856064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.
    Grenier A; Lescault A; Laberge C; Gagné R; Mamer O
    Clin Chim Acta; 1982 Aug; 123(1-2):93-9. PubMed ID: 7116642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of heme in the transcriptional activation of CYPIIB1/B2 gene by phenobarbitone in rat liver--studies with succinylacetone.
    Venkateswar V; Padmanaban G
    Arch Biochem Biophys; 1991 Oct; 290(1):167-72. PubMed ID: 1898087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite.
    Surolia N; Padmanaban G
    Biochem Biophys Res Commun; 1992 Sep; 187(2):744-50. PubMed ID: 1356337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue variant effects of heme inhibitors on the mouse cytochrome c oxidase gene expression and catalytic activity of the enzyme complex.
    Vijayasarathy C; Damle S; Lenka N; Avadhani NG
    Eur J Biochem; 1999 Nov; 266(1):191-200. PubMed ID: 10542064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute depletion of heme by succinylacetone alters vascular responses but does not induce hypertension.
    Soong J; Adams MA; Nakatsu K
    Can J Physiol Pharmacol; 2008 Sep; 86(9):613-9. PubMed ID: 18758510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of succinylacetone on growth and respiration of L1210 leukemia cells.
    Weinbach EC; Ebert PS
    Cancer Lett; 1985 Apr; 26(3):253-9. PubMed ID: 3995499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of hematin and growth of malignant murine erythroleukemia cells depleted of endogenous heme by succinylacetone.
    Ebert PS; Frykholm BC; Hess RA; Tschudy DP
    Cancer Res; 1981 Mar; 41(3):937-41. PubMed ID: 6936078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of haem biosynthesis in the control of intestinal iron absorption.
    Laftah A; Raja KB; Simpson RJ; Peters TJ
    Biochem Soc Trans; 1997 Feb; 25(1):58S. PubMed ID: 9056956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.